MGX vs STZ · rev $25.2M vs P/E 14, rev $9.14B
Metagenomi, Inc. Common Stock (MGX) versus Constellation Brands Inc Class A (STZ) — a side-by-side from cached financials, not a winner call.
Metagenomi, Inc. Common Stock (MGX) is a biotechnology company listed on NASDAQ.
Constellation Brands Inc Class A (STZ) is a beverages - brewers company listed on US.
Latest reported MGX revenue for 2025-12-31 was $25.2M. Net income was -$87.9M. Revenue was down 51.8% from 2024-12-31 to 2025-12-31. MGX currently screens at market cap $44.4M.
Latest reported STZ revenue for 2026-02-28 was $9.14B. Net income was $1.69B. Revenue was up 322.3% from 2025-02-28 to 2026-02-28. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
MGX currently screens at market cap $44.4M. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
Not investment advice. Open the MGX and STZ stock pages for the full models.
Not investment advice.